Download Files:
LSD1-IN-27
SKU
HY-155115-Get quote
Category Reference compound
Tags Cancer, Epigenetics;Immunology/Inflammation, Histone Demethylase;PD-1/PD-L1
Products Details
Product Description
– LSD1-IN-27 (Compound 5ac) is a LSD1 inhibitor (IC50: 13 nM). LSD1-IN-27 inhibits the stemness and migration of gastric cancer cells. LSD1-IN-27 also reduces the expression of PD-L1 in BGC-823 and MFC cells. LSD1-IN-27 can enhance T cell immune response in gastric cancer[1].
Web ID
– HY-155115
Shipping
– Room temperature
Molecular Formula
– C24H25N3
References
– [1]Dai XJ, et al. Novel acridine-based LSD1 inhibitors enhance immune response in gastric cancer. Eur J Med Chem. 2023 Nov 5;259:115684.
CAS Number
– 2904571-94-2
Molecular Weight
– 355.48
SMILES
– CC1=CC=C2C(C(NC3=CC=C(N(C)C)C=C3)=C4C(C(C)=C(C)C=C4)=N2)=C1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Histone Demethylase;PD-1/PD-L1
Pathway
– Epigenetics;Immunology/Inflammation
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.